TLR4-mediated activation of microglia in the early stage of AD protects neurons by limiting Aβ deposition [368]; however, sustained Aβ exposure and TLR4 activation during disease progression alters microglial response by promoting a switch from the phagocytic phenotype to a neurotoxic phenotype [367,369]. This evidence concerns the gene TLR4 and Alzheimer disease.